These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34303285)

  • 1. Generation of an induced pluripotent stem cell line (UCSCi001-A) from a patient with early-onset amyotrophic lateral sclerosis carrying a FUS variant.
    Martello F; Lattante S; Doronzio PN; Conte A; Bisogni G; Orteschi D; Pirozzi F; Sabatelli M; Zollino M; Marangi G
    Stem Cell Res; 2021 Aug; 55():102461. PubMed ID: 34303285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of an induced pluripotent stem cell line (UCSCi002-A) from a patient with a variant in TARDBP gene associated with familial amyotrophic lateral sclerosis and frontotemporal dementia.
    Martello F; Lattante S; Doronzio PN; Conte A; Bisogni G; Orteschi D; Luigetti M; Marrucci MA; Zollino M; Sabatelli M; Marangi G
    Stem Cell Res; 2022 Jul; 62():102825. PubMed ID: 35667216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fused in sarcoma protein forms cytoplasmic aggregates in motor neurons derived from integration-free induced pluripotent stem cells generated from a patient with familial amyotrophic lateral sclerosis carrying the FUS-P525L mutation.
    Liu X; Chen J; Liu W; Li X; Chen Q; Liu T; Gao S; Deng M
    Neurogenetics; 2015 Jul; 16(3):223-31. PubMed ID: 25912081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of a human induced pluripotent stem cell line (SMUSHi002-A) from an ALS patient carrying a heterozygous mutation c.1562G > A in the FUS gene.
    Tang M; Xiong M; Zhou W; Lei J; Huang M; Huang C; Wang F; Liu J; Li J; Xu X
    Stem Cell Res; 2024 Feb; 74():103286. PubMed ID: 38141357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of In Vitro FUS-Associated Familial Amyotrophic Lateral Sclerosis Model Using Human Induced Pluripotent Stem Cells.
    Ichiyanagi N; Fujimori K; Yano M; Ishihara-Fujisaki C; Sone T; Akiyama T; Okada Y; Akamatsu W; Matsumoto T; Ishikawa M; Nishimoto Y; Ishihara Y; Sakuma T; Yamamoto T; Tsuiji H; Suzuki N; Warita H; Aoki M; Okano H
    Stem Cell Reports; 2016 Apr; 6(4):496-510. PubMed ID: 26997647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of two induced pluripotent stem cell lines with heterozygous and homozygous amyotrophic lateral sclerosis-causing mutation P525L (c.1574C > T) in FUS gene.
    Akter M; Cui H; Abir Hosain M; Ding B
    Stem Cell Res; 2023 Jun; 69():103103. PubMed ID: 37116345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of an Open-Access Patient-Derived iPSC Biobank for Amyotrophic Lateral Sclerosis Disease Modelling.
    Hedges EC; Cocks G; Shaw CE; Nishimura AL
    Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-Aminopyridine Induced Activity Rescues Hypoexcitable Motor Neurons from Amyotrophic Lateral Sclerosis Patient-Derived Induced Pluripotent Stem Cells.
    Naujock M; Stanslowsky N; Bufler S; Naumann M; Reinhardt P; Sterneckert J; Kefalakes E; Kassebaum C; Bursch F; Lojewski X; Storch A; Frickenhaus M; Boeckers TM; Putz S; Demestre M; Liebau S; Klingenstein M; Ludolph AC; Dengler R; Kim KS; Hermann A; Wegner F; Petri S
    Stem Cells; 2016 Jun; 34(6):1563-75. PubMed ID: 26946488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients.
    Guo W; Naujock M; Fumagalli L; Vandoorne T; Baatsen P; Boon R; Ordovás L; Patel A; Welters M; Vanwelden T; Geens N; Tricot T; Benoy V; Steyaert J; Lefebvre-Omar C; Boesmans W; Jarpe M; Sterneckert J; Wegner F; Petri S; Bohl D; Vanden Berghe P; Robberecht W; Van Damme P; Verfaillie C; Van Den Bosch L
    Nat Commun; 2017 Oct; 8(1):861. PubMed ID: 29021520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of six induced pluripotent stem cell lines from patients with amyotrophic lateral sclerosis with associated genetic mutations in either FUS or ANXA11.
    Hedges EC; Topp S; Shaw CE; Nishimura AL
    Stem Cell Res; 2021 Apr; 52():102246. PubMed ID: 33610019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of two induced pluripotent stem cell lines with heterozygous and homozygous amyotrophic lateral sclerosis-causing mutation R521G (c.1561C > G) in FUS gene.
    Akter M; Cui H; Abir Hosain M; Ding B
    Stem Cell Res; 2023 Jun; 69():103078. PubMed ID: 36965406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALS mutant FUS proteins are recruited into stress granules in induced pluripotent stem cell-derived motoneurons.
    Lenzi J; De Santis R; de Turris V; Morlando M; Laneve P; Calvo A; Caliendo V; Chiò A; Rosa A; Bozzoni I
    Dis Model Mech; 2015 Jul; 8(7):755-66. PubMed ID: 26035390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs.
    Wang L; Yi F; Fu L; Yang J; Wang S; Wang Z; Suzuki K; Sun L; Xu X; Yu Y; Qiao J; Belmonte JCI; Yang Z; Yuan Y; Qu J; Liu GH
    Protein Cell; 2017 May; 8(5):365-378. PubMed ID: 28401346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stepwise acquirement of hallmark neuropathology in FUS-ALS iPSC models depends on mutation type and neuronal aging.
    Japtok J; Lojewski X; Naumann M; Klingenstein M; Reinhardt P; Sterneckert J; Putz S; Demestre M; Boeckers TM; Ludolph AC; Liebau S; Storch A; Hermann A
    Neurobiol Dis; 2015 Oct; 82():420-429. PubMed ID: 26253605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Directly converted patient-specific induced neurons mirror the neuropathology of FUS with disrupted nuclear localization in amyotrophic lateral sclerosis.
    Lim SM; Choi WJ; Oh KW; Xue Y; Choi JY; Kim SH; Nahm M; Kim YE; Lee J; Noh MY; Lee S; Hwang S; Ki CS; Fu XD; Kim SH
    Mol Neurodegener; 2016 Jan; 11():8. PubMed ID: 26795035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant axon branching via Fos-B dysregulation in FUS-ALS motor neurons.
    Akiyama T; Suzuki N; Ishikawa M; Fujimori K; Sone T; Kawada J; Funayama R; Fujishima F; Mitsuzawa S; Ikeda K; Ono H; Shijo T; Osana S; Shirota M; Nakagawa T; Kitajima Y; Nishiyama A; Izumi R; Morimoto S; Okada Y; Kamei T; Nishida M; Nogami M; Kaneda S; Ikeuchi Y; Mitsuhashi H; Nakayama K; Fujii T; Warita H; Okano H; Aoki M
    EBioMedicine; 2019 Jul; 45():362-378. PubMed ID: 31262712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in FUS lead to synaptic dysregulation in ALS-iPSC derived neurons.
    Shum C; Hedges EC; Allison J; Lee YB; Arias N; Cocks G; Chandran S; Ruepp MD; Shaw CE; Nishimura AL
    Stem Cell Reports; 2024 Feb; 19(2):187-195. PubMed ID: 38242131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FUS Mutant Human Motoneurons Display Altered Transcriptome and microRNA Pathways with Implications for ALS Pathogenesis.
    De Santis R; Santini L; Colantoni A; Peruzzi G; de Turris V; Alfano V; Bozzoni I; Rosa A
    Stem Cell Reports; 2017 Nov; 9(5):1450-1462. PubMed ID: 28988989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production and validation of human induced pluripotent stem cell line from sporadic amyotrophic lateral sclerosis (SALS).
    Ma J; Feng B; Kong D; He J; Guo R; Amponsah AE; Zhang W; Zhang S; Lv F; Song Y; Liu A; Cui H
    Stem Cell Res; 2020 Apr; 44():101760. PubMed ID: 32203916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.